⭐ Get Excited ⭐
I'm honored to host Julio G. Martinez-Clark, CEO of bioaccess®: Fast-Tracking First-in-Human Trials, Anywhere®, for an insightful conversation on medical innovation and global clinical trials.
Why should you listen to Julio?
As CEO, he has led multidisciplinary teams that fuse engineering, regulatory, and clinical expertise to make advanced cyclotron programs turnkey. From feasibility modeling to GMP validations, they compress timelines, cut capital risk, and empower hospitals and research centers to own their isotope destiny.
Key wins:
• Launched full-service cyclotron hubs in North America, Europe, Asia-Pacific, and MENA, standardizing SOPs across divergent health systems.
• Secured sub-12-month regulatory approvals and 30% lower operating costs through proprietary digital QMS and remote monitoring.
• Orchestrated data-sharing alliances with leading PET-CT networks, unlocking faster patient enrollment for precision-oncology trials. • Deployed MyoFlow™ analytics globally, elevating cardiac PET throughput while enhancing diagnostic accuracy.
• Embedded ISO, GMP, and radiation-safety compliance into every project, ensuring enduring quality wherever we operate.
🔥 Takeaways from the podcast:
✅ Innovation starts at the intersection of market demand and clinical possibility—not just in the lab.
✅ Balancing scientific rigor with speed is the new competitive advantage in MedTech.
✅ Running clinical trials in regions like Latin America or Australia offers untapped advantages—cost, speed, and patient access.
✅ Timeline compression isn't just a buzzword—it’s an investor confidence booster that directly impacts capital raising.
✅ Series A/B investors are hungry for efficiency, global scalability, and a clear regulatory roadmap.
✅ If bioaccess® reaches its <8-week first-patient-in goal, the entire approval lifecycle could be redefined.
✅ Regulatory frameworks in the U.S. and EU must evolve—or risk falling behind emerging markets in innovation pace.
🎧 Subscribe, share, and stay tuned. This conversation will challenge your assumptions—and inspire your next move.
🎙️From Idea to Approval: How Medical Innovation Gets Funded and Fast-Tracked
📍 Podcast Location: Umatta Consulting on Spotify
📅 Aug 11 | ⏰ 10:30 AM EST
💡 Featuring Julio G. Martinez-Clark, CEO of bioaccess® | Fast-Tracking First-in-Human Trials Worldwide | 40% Faster Approvals, 30% Lower Costs | Medtech, Biopharma, and Radiopharma Partner
🔗 Follow us on Spotify here: https://lnkd.in/dKD7CPu9
#MedTech #Biopharma #ClinicalResearch #Innovation #HealthcareFunding #MedicalInnovation #Leadership #RegulatoryStrategy #GlobalTrials #LatAm #StartupSuccess #SeriesA/B #DigitalHealth #UmattaConsulting #Podcast